Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials-Reference-Cited by-同舟云学术

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials

Published:2020-05 Issue:5 Volume:8 Page:461-474
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Bernstein Jonathan A,Virchow J Christian,Murphy Kevin,Maspero Jorge Fernando,Jacobs Joshua,Adir Yochai,Humbert Marc,Castro Mario,Marsteller Douglas A,McElhattan Jennifer,Hickey Lisa,Garin Margaret,Vanlandingham Rebecca,Brusselle Guy

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference21 articles.

1. Tissue remodeling and angiogenesis in asthma: the role of the eosinophil;Nissim Ben Efraim;Ther Adv Respir Dis,2008

2. Defining phenotypes in asthma: a step towards personalized medicine;Chung;Drugs,2014

3. High blood eosinophil count is associated with more frequent asthma attacks in asthma patients;Tran;Allergy Asthma Immunol,2014

4. Elevated blood eosinophil level is a risk factor for exacerbations in adult persistent asthma;Zeiger;Am J Respir Crit Care Med,2014

5. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5);Campbell;Proc Natl Acad Sci USA,1987

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the risk of infection events in patients with asthma receiving anti-IL-5 monoclonal antibodies: A rapid systematic review and a meta-analysis;Heliyon;2024-01

2. Efficacy and Safety of Biologics for Oral Corticosteroid–Dependent Asthma: A Systematic Review and Network Meta-Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2023-11

3. Severe Asthma Patients: Can We Really Wean Them off of Oral Corticosteroids;Current Treatment Options in Allergy;2023-10-11

4. Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience;Respiratory Medicine;2023-10

5. Severe Asthma Patients: Can We Really Wean Them off of Oral Corticosteroids;CURR TREAT OPTION AL;2023